Home / Japan / Noile-Immune Biotech Inc.
Noile-Immune Biotech Inc.
Short position disclosed on September 24, 2026.
0.83% of the capital sold short
1 disclosing fund
5 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%
Aug 26Sep 3Sep 11Sep 19
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| 大和証券株式会社 | 0.83% | -0.41 pt | September 24, 2026 |
Get the moves on Noile-Immune Biotech Inc. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 24, 2026 | 大和証券株式会社 | 0.83% | still open |
| September 1, 2026 | 大和証券株式会社 | 0.99% | |
| August 26, 2026 | 大和証券株式会社 | 1.08% | |
| August 21, 2026 | 大和証券株式会社 | 1.16% | |
| August 18, 2026 | 大和証券株式会社 | 1.24% |
Download 5 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- ReYuu Japan Inc. 17.05% of the capital sold short
- Metaplanet Inc. 12.03% of the capital sold short
- Jibannet Holdings Co.,Ltd. 10.36% of the capital sold short
- Unitika LTD. 9.42% of the capital sold short
- KLab Inc. 8.13% of the capital sold short
- Tri Chemical Laboratories Inc. 7.99% of the capital sold short
- Sanrio Company,Ltd. 7.52% of the capital sold short
- Money Forward,Inc. 7.34% of the capital sold short
- Datasection Inc. 7.31% of the capital sold short
- Toyo Engineering Corporation 7.28% of the capital sold short
- Kasumigaseki Capital Co.,Ltd. 7.17% of the capital sold short
- Towa Corporation 7.11% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Noile-Immune Biotech Inc., source JPX, data as at September 24, 2026, https://www.quivad.com/action/noile-immune-biotech-inc